MetLife, Inc. (NYSE:MET) Stake Increased by Investors Research Corp

Investors Research Corp lifted its stake in MetLife, Inc. (NYSE:METFree Report) by 1.2% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 17,150 shares of the financial services provider’s stock after acquiring an additional 200 shares during the quarter. Investors Research Corp’s holdings in MetLife were worth $1,415,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in MET. MeadowBrook Investment Advisors LLC grew its stake in shares of MetLife by 244.4% during the third quarter. MeadowBrook Investment Advisors LLC now owns 310 shares of the financial services provider’s stock valued at $26,000 after purchasing an additional 220 shares during the last quarter. Carmichael Hill & Associates Inc. raised its position in shares of MetLife by 131.9% during the third quarter. Carmichael Hill & Associates Inc. now owns 327 shares of the financial services provider’s stock worth $27,000 after acquiring an additional 186 shares during the last quarter. Wolff Wiese Magana LLC boosted its holdings in MetLife by 374.3% in the third quarter. Wolff Wiese Magana LLC now owns 351 shares of the financial services provider’s stock valued at $29,000 after acquiring an additional 277 shares during the last quarter. Peterson Financial Group Inc. bought a new stake in MetLife during the 3rd quarter worth about $30,000. Finally, Fortitude Family Office LLC lifted its position in MetLife by 177.3% during the 3rd quarter. Fortitude Family Office LLC now owns 416 shares of the financial services provider’s stock valued at $34,000 after purchasing an additional 266 shares during the period. 89.81% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several equities analysts have weighed in on the company. Morgan Stanley cut their target price on MetLife from $86.00 to $85.00 and set an “overweight” rating on the stock in a research note on Monday, August 19th. Jefferies Financial Group upped their price target on shares of MetLife from $89.00 to $95.00 and gave the stock a “buy” rating in a research report on Friday, September 27th. Bank of America decreased their target price on MetLife from $99.00 to $96.00 and set a “buy” rating on the stock in a report on Thursday, August 1st. Barclays reduced their target price on shares of MetLife from $91.00 to $90.00 and set an “overweight” rating for the company in a research report on Thursday, October 31st. Finally, Piper Sandler lifted their price target on shares of MetLife from $85.00 to $92.00 and gave the company an “overweight” rating in a research report on Wednesday, October 2nd. Fourteen investment analysts have rated the stock with a buy rating, According to MarketBeat.com, MetLife presently has an average rating of “Buy” and an average price target of $88.46.

Check Out Our Latest Report on MET

MetLife Stock Up 1.9 %

Shares of NYSE:MET traded up $1.53 on Thursday, hitting $84.13. 248,030 shares of the company traded hands, compared to its average volume of 3,302,894. The company has a market cap of $58.25 billion, a PE ratio of 16.65, a PEG ratio of 0.75 and a beta of 1.05. MetLife, Inc. has a 52 week low of $62.15 and a 52 week high of $86.94. The company has a quick ratio of 0.16, a current ratio of 0.16 and a debt-to-equity ratio of 0.51. The stock has a 50 day simple moving average of $82.08 and a 200-day simple moving average of $75.84.

MetLife Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Monday, December 16th. Shareholders of record on Tuesday, November 5th will be issued a dividend of $0.545 per share. The ex-dividend date is Tuesday, November 5th. This represents a $2.18 dividend on an annualized basis and a yield of 2.59%. MetLife’s dividend payout ratio is currently 43.95%.

MetLife Profile

(Free Report)

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.

See Also

Institutional Ownership by Quarter for MetLife (NYSE:MET)

Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.